ADVERTISEMENT

Buy, Sell Or Hold: L&T, Stylam Industries, PVR Inox, Kalyan Jewellers, Swiggy — Ask Profit

Analysts also shared insights for short-term and long-term investors on the share prices of Ashapura Minechem and IOL Chemicals & Pharmaceuticals.

<div class="paragraphs"><p>Analysts also shared insights on share prices of Larsen &amp; Toubro (L&amp;T), Stylam Industries, PVR Inox, Kalyan Jewellers, Ashapura Minechem, Swiggy, IOL Chemicals &amp; Pharmaceuticals (Buy, sell. Image:&nbsp;<a href="https://www.freepik.com/author/starline">starline</a>/Freepik)</p></div>
Analysts also shared insights on share prices of Larsen & Toubro (L&T), Stylam Industries, PVR Inox, Kalyan Jewellers, Ashapura Minechem, Swiggy, IOL Chemicals & Pharmaceuticals (Buy, sell. Image: starline/Freepik)

Should you buy shares of Larsen & Toubro Ltd. at the current market price? Have you lost the opportunity to buy stocks of Ashapura Minechem Ltd.? Is IOL Chemicals & Pharmaceuticals Ltd. a good choice from a long-term perspective? Should you sell shares of PVR Inox Ltd. at the current market price?

Prashanth Tapse, senior vice president of research at Mehta Equities, and Sarvendra Srivastava, market strategist at 5 Waves, answered these investor queries and provided more insights on NDTV Profit's Ask Profit show.

Larsen & Toubro (CMP: Rs 3,421.65) 

Prashanth: Sell

  • Quarter-four earnings for an infrastructure firm like L&T are anticipated to be weak.

  • The stock is experiencing consolidation and pressure from both fundamental and technical perspectives.

  • Analysts currently recommend selling the stock.

Opinion
L&T Wins Its Largest Order Worth Over Rs 15,000 Crore From QatarEnergy LNG

Stylam Industries (CMP: 1,690.85)

Prashanth: Buy

  • The analyst has a highly optimistic outlook for the sector, noting its rapid progress on a fundamental level.

  • The company's current fundamentals are strong, with a return on capital of approximately 33%.

  • Based on valuations, the stock is well-suited for buying and holding.

PVR Inox (CMP: Rs 967.70)

Prashanth: Sell

  • OTT platforms are significantly impacting the company's business both in the short term and the long term.

  • The analyst has maintained a bearish stance on the stock since it was trading at Rs 1,200.

  • The analyst recommendation for investors is to sell the stock. The outlook remains highly negative.

Opinion
Old Hits, New Business: How Nostalgia Is Filling Cinemas Again—And PVR Inox Is Cashing In

Kalyan Jewellers India (CMP: Rs 512.10)

Prashanth: Partial sell

  • The analyst advises partial booking of stocks at the current market price at fundamental valuation basis.

  • Not comfortable to have very aggressive targets at the current levels.

  • But this can also be some kind of bounce the investor can use to book profits.

Opinion
Kalyan Jewellers Eyes Margin Expansion From FY27 With COCO Model

Ashapura Minechem (CMP: Rs 379.15)

Prashanth: Positive

  • The analyst holds a positive view of the company, citing strong fundamental ratios.

  • From a price perspective, investors may consider accumulating the stock now, as it shows signs of attracting buying interest at its current market level.

  • The company operates in diverse sectors, including edible oil, metals, and medicines, with its conglomerate business model offering strong long-term potential.

Swiggy (CMP: Rs 344.80)

Sarvendra: Re-bounce expected

  • Early data indicates that the stock is currently experiencing a decline.

  • This marks the first month with a flat close. However, the past couple of weeks show promising signs.

  • A rebound in the stock is anticipated, provided it stays above the Rs 300 level.

Opinion
Pension For Gig Workers: Government May Ask Swiggy, Zomato, Uber To Pay 2% Of Earnings

IOL Chemicals (CMP: Rs 63.39)

Prashanth: Wait and Watch

  • The company is fundamentally strong but appears aggressive in terms of ratios and fundamentals at the moment.

  • Investors are advised to wait and monitor the stock at Rs 55–60 levels before accumulating it for the long term.

  • Being one of the largest global manufacturers of painkillers, the company's primary buying trigger is its leadership in this segment.

  • Analysts suggest Rs 58–60 as an ideal range to buy the stock, while cautioning against an aggressive approach, given the current fundamentals and ratios.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.

Opinion
Trade Setup For April 3: Nifty Finds Immediate Resistance At 23,400
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit